Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Parexel announced Gavin Nichols has joined the company as Executive Vice President, Informatics and Information Technology.
read more
Thursday, October 03, 2019
Parexel announced the company has appointed John Bell Executive Vice President and Chief Quality Officer.
read more
Monday, September 26, 2016
PAREXEL International Corporation has announced that the company has entered into a definitive agreement to acquire ExecuPharm, Inc., a global functional service provider (FSP) serving the biopharmaceutical industry. The acquisition is expected to ...
read more
Monday, December 18, 2017
PAREXEL has introduced its enhanced Global Data Operations solution.
read more
Parexel has unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks.
read more
Monday, November 12, 2018
PAREXEL announced the appointment of new members to the Board of Directors following Pamplona Capital Management’s acquisition in September 2017.
read more
PAREXEL announced the appointment of Peyton Howell as Chief Commercial and Strategy Officer, effective May 7, 2018.
read more
Thursday, November 08, 2018
SHYFT Analytics and PAREXEL announced the companies have entered into a strategic partnership that establishes SHYFT’s technology as an integral part of PAREXEL’s foundation for Real-World Evidence (RWE) generation and outcomes research for ...
read more
Tuesday, November 27, 2012
PAREXEL International Corporation, a leading global biopharmaceutical services provider, and the National Taiwan University Hospital (NTUH) announced today that they have established an alliance. Under the agreement, PAREXEL and NTUH will collaborate...
read more
PAREXEL International Corporation and EMC Corporation have entered into an alliance to offer an end-to-end Regulatory Information Management (RIM) and Regulatory Content Management solution.
read more
Parcom Capital has acquired clinical research organization Viroclinics Biosciences.
read more
Paratek Pharmaceuticals Inc announced that Paratek has delivered the first procurement of NUZYRA to the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR)...
read more
Paratek Pharmaceuticals announced it has entered into a collaboration with Zai Lab, a biopharmaceutical company based in China, to support the development and commercialization of omadacycline for patients in China.
read more
Paratek Pharmaceuticals, Inc. announced the receipt of a $36.4 million milestone payment associated with the second procurement of NUZYRA® (omadacycline) under the company’s Project BioShield contract with the Biomedical Advanced Research and ...
read more
Paratek announced BARDA has initiated funding to support the onshoring of Paratek manufacturing activities for NUZYRA.
read more